Treatment Decision

Treatment Decision - most related articles:

- NICE's decision on Alzheimer's drugs based on flawed calculations - 3.6
- Hannah Jones refused heart transplant surgery - 3.1
- FDA panel votes to revoke approval for Avastin for advanced breast cancer - 2.9
- Breast cancer sufferers demand answers from PHARMAC, New Zealand - 2.6
- HIV testing compulsory before marriage in India - 2.5
- Breast cancer screening mammography not a true life saver - 2.4
- Isolated DNA Claims are Not Patentable, US - 2.3
- 7% breast cancer patients have breast reconstruction surgery - 2.2
- Susan G. Komen stops funding breast cancer programs at Planned Parenthood - 2.2
- Statin may raise stroke risk in patients with brain hemorrhage - 2.1

Treatment Decision articles

Investments for children must be at top of African HIV and AIDS agenda - UNICEF
All children, particularly the poorest and most marginalized, should have access to HIV/AIDS prevention, treatment and care. Against the background of reduced funding for HIV/AIDS activities, partners and decision makers must sustain their contributions to make this world HIV free.

More aggressive treatment not necessary for men with a family history of prostate cancer
Approximately 10-20 percent of prostate cancer patients have a family history of the disease. There are three major factors that are used to evaluate the extent and aggressiveness of prostate cancer, help make treatment decisions, and estimate prognosis: the Prostate Specific Antigen Level (PSA), Gleason score (GS) from the biopsy, and the digital rectal exam findings (DRE).

New urine test can detect prostate cancer risk early
A new urine test can help aid early detection of and treatment decisions about prostate cancer. Examining the urine sample for TMPRSS2:ERG and PCA3 and stratified patient into low, intermediate and high score, indicating their risk of cancer can help.

Niacin and statin treatment did not protect heart
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned.

Gene based prostate cancer test may make more accurate treatment decisions
Researchers conducted an elaborate series of experiments to identify the genes most closely linked to the aggressive biology of prostate cancer. They found about 300 genes that distinguished the two groups - indolent versus aggressive prostate cancers.

Age plays too big a role in prostate cancer treatment decisions
Older men with high-risk prostate cancer frequently are offered fewer – and less effective – choices of treatment than younger men, potentially resulting in earlier deaths, according to a new UCSF study.

Gene linked to aggressive form of prostate cancer
Researchers at Wake Forest University Baptist Medical Center and colleagues have identified the first genetic variant associated with aggressive prostate cancer, proving the concept that genetic information may one day be used in combination with other factors to guide treatment decisions.

Prostate cancer impacts quality of life of patient
A long-term study by researchers at UCLA's Jonsson Comprehensive Cancer Center found that the three most common treatments for localized prostate cancer had significant impacts on patients' quality of life, a finding that could help guide doctors and patients in making treatment decisions.

8 Treatment Decision articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
6.7